Timing adjustments alone will not prevent GLP-1 related hair loss , which is typically caused by rapid weight loss and nutritional deficiencies rather than the timing of the injection itself
When you factor in the superior weight loss (which reduces obesity-related healthcare costs), fewer injections (which reduces supply costs), and better metabolic outcomes, tirzepatide provides more value per dollar spent, even at comparable or higher monthly prices
The new 5-HT hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
Current conservative interventions for OA, such as physical workouts and oral nonsteroidal anti-inflammatory drugs (NSAIDs), seek to mitigate the disease's development during its early to mid-stages [11]
This might trigger the body to release GLP-1, aiding in appetite regulation and potentially supporting weight loss efforts
74 However, RCTs are still needed to investigate the effects of GLP-1 RAs on HF outcomes, mortality and clinical outcomes in both HFpEF and HFrEF
